Breaking barriers: Expansion of the use of endolysins as novel antibacterials against Gram-negative bacteria

Future Microbiology

Volumn 10, Issue 3, 2015, Pages 377-390

  Briers, Yves ^a   Lavigne, Rob ^a  

^a LABORATORY OF GENE TECHNOLOGY   (Belgium)

Author keywords

Antibiotic resistance; Art 175; Artilysin ; Endolysin; Gram negative; Novel antibiotics; Outer membrane

Indexed keywords

ANTIINFECTIVE AGENT; ARTILYSIN; ENDOLYSIN; LYSOZYME; UNCLASSIFIED DRUG; PEPTIDOGLYCAN; PROTEINASE;

ANTIBACTERIAL ACTIVITY; BACTERIAL OUTER MEMBRANE; BACTERIOPHAGE; DRUG UPTAKE; GRAM NEGATIVE BACTERIUM; HUMAN; MEMBRANE PERMEABILITY; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTEIN ENGINEERING; PROTEIN STRUCTURE; REVIEW; ANIMAL; BACTERIOLYSIS; DRUG EFFECTS; GRAM POSITIVE BACTERIUM; GRAM-NEGATIVE BACTERIAL INFECTIONS; METABOLISM; VETERINARY;

BACTERIA (MICROORGANISMS); METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NEGIBACTERIA; POSIBACTERIA;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIOLYSIS; ENDOPEPTIDASES; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIA; HUMANS; PEPTIDOGLYCAN; PROTEIN ENGINEERING;

EID: 84926179791     PISSN: 17460913     EISSN: 17460921     Source Type: Journal    
DOI: 10.2217/FMB.15.8     Document Type: Review

References (67)

1. Fleming A. On the antibacterial action of cultures of a penicillium, with special reference to their use in the isolation of B. influenza. Brit. J. Exp. Path. 10(3), 226-236 (1929).
2. Lewis K. Platforms for antibiotic discovery. Nat. Rev. Drug Disc. 12(5), 371-387 (2013).
3. Li JW-H, Vederas JC. Drug discovery and natural products: end of an era or an endless frontier. Science 325(5937), 161-165 (2009).
4. Mandal SM, Roy A, Ghosh AK, Hazra TP, Basak A, Franco OL. Challenges and future prospects of antibiotic therapy: from peptides to phages utilization. Front. Pharmacol. 5, 105 (2014).
5. Schmelcher M, Donovan DM, Loessner MJ. Bacteriophage endolysins as novel antimicrobials. Future Microbiol. 7(10), 1147-1171 (2012).
6. Fleming A. On a remarkable bacteriolytic element found in tissues and secretion. Proc. Roy. Soc. Ser. B 93, 306-317 (1922).
7. Masschalck B, Michiels CW. Antimicrobial properties of lysozyme in relation to foodborne vegetative bacteria. Crit. Rev. Microbiol. 29(3), 191-214 (2003).
8. Rodríguez-Rubio L, Martínez B, Donovan D, Rodríguez A, García P. Bacteriophage virion-associated peptidoglycan hydrolases: potential new enzybiotics. Crit. Rev. Microbiol. 39(4), 427-434 (2013).
9. Briers Y, Volckaert G, Cornelissen A et al. Muralytic activity and modular structure of the endolysins of Pseudomonas aeruginosa bacteriophages phiKZ and EL. Mol. Microbiol. 65(5), 1334-1344 (2007).
10. Briers Y, Miroshnikov K, Chertkov O et al. The structural peptidoglycan hydrolase gp181 of bacteriophage KZ. Biochem. Biophys. Res. Comm. 374(4), 747-751 (2008).
11. Nelson D, Loomis L, Fischetti VA. Prevention and elimination of upper respiratory colonization of mice by group A streptococci by using a bacteriophage lytic enzyme. Proc. Natl. Acad. Sci. USA 98(7), 4107-4112 (2001).
12. Loeffler JM, Nelson D, Fischetti VA. Rapid killing of Streptococcus pneumonia with a bacteriophage cell wall hydrolase. Science 294(5549), 2170-2172 (2001).
13. Schmelcher M, Powell AM, Becker SC, Camp MJ, Donovan DM. Chimeric phage lysins act synergistically with lysostaphin to kill mastitis-causing Staphylococcus aureus in murine mammary glands. Appl. Environ. Microbiol. 78(7), 2297-2305 (2012).
14. Schuch R, Nelson D, Fischetti VA. A bacteriolytic agent that detects and kills Bacillus anthracis. Nature 418(6900), 884-849 (2002).
15. Hermoso JA, García JL, García P. Taking aim on bacterial pathogens: from phage therapy to enzybiotics. Curr. Opin. Microbiol. 10(5), 461-472 (2007).
16. Fischetti VA. Bacteriophage endolysins: a novel anti-infective to control Gram-positive pathogens. Int. J. Med. Microbiol. 300(6), 357-362 (2010).
17. Nelson DC, Schmelcher M, Rodriguez-Rubio L et al. Endolysins as antimicrobials. Adv. Virus Res. 83, 299-365 (2012).
18. Walmagh M, Boczkowska B, Grymonprez B, Briers Y, Drulis-Kawa Z, Lavigne R. Characterization of five novel endolysins from Gram-negative infecting bacteriophages. Appl. Microbiol. Biotechnol. 97(10), 4369-4375 (2013).
19. Schleifer KH, Kandler O. Peptidoglycan types of bacterial cell walls and their taxonomic implications. Bact. Rev. 36(4), 407-477 (1972).
20. Loessner MJ. Bacteriophage endolysins - current state of research and applications. Curr. Opin. Microbiol. 8(4), 480-487 (2005).
21. Plotka M, Kaczorowska AK, Stefanska A et al. Novel highly thermostable endolysin from Thermus scotoductus MAT2119 bacteriophage Ph2119 with amino acid sequence similarity to eukaryotic peptidoglycan recognition proteins. Appl. Environ. Microbiol. 80(3), 886-895 (2014).
22. Kitti T, Thummeepak R, Thanwisai A et al. Characterization and detection of endolysin gene from three Acinetobacter baumannii bacteriophages isolated from sewage water. Indian J. Microbiol. 54(4), 383-388 (2014).
23. Oliveira H, Thiagarajan V, Walmagh M et al. A thermostable Salmonella phage endolysin, Lys68, with broad bactericidal properties against Gram-negative pathogens in presence of weak acids. PLoS One 9(10), e108376 (2014).
24. Legotsky SA, Vlasova KY, Priyma AD et al. Peptidoglycan degrading activity of the broad-range Salmonella bacteriophage S-394 recombinant endolysin. Biochimie 107(Pt B), 293-299 (2014).
25. Han F, Li M, Lin H, Wang J, Cao L, Khan MN. The novel Shewanella putrefaciens-infecting bacteriophage Spp001: genome sequence and lytic enzymes. J. Ind. Microbiol. Biotechnol. 41(6), 1017-1026 (2014).
26. Lim JA, Shin H, Heu S, Ryu S. Exogenous lytic activity of SPN9CC endolysin against gram-negative bacteria. J. Microbiol. Biotechnol. 24(6), 803-811 (2014).
27. Park Y, Lim JA, Kong M, Ryu S, Rhee S. Structure of bacteriophage SPN1S endolysin reveals an unusual two-module fold for the peptidoglycan lytic and binding activity. Mol. Microbiol. 92(2), 316-325 (2014).
28. Shin H, Lee JH, Yoon H, Kang DH, Ryu S. Genomic investigation of lysogen formation and host lysis systmes of the Salmonella temperate bacteriophage SPN9CC. Appl. Environ. Microbiol. 80(1), 374-384 (2014).
29. Oliveira H, Melo LDR, Santos SB, Nóbrega FL et al. Molecular aspects and comparative genomics of bacteriophage endolysins. J. Virol. 87(8), 4558-4570 (2013).
30. García P, García JL, García E, Sanchez- Puelles JM, Lopez R. Modular organization of the lytic enzymes of Streptococcus pneumoniae and its bacteriophages. Gene 86(1), 81-88 (1990).
31. Eugster MR, Haug MC, Huwiler SG, Loessner MJ. The cell wall binding domain of Listeria bacteriophage endolysin PlyP35 recognizes terminal GlcNAc residues in cell wall teichoic acid. Mol. Microbiol. 81(6), 1419-1432 (2011).
32. Briers Y, Schelcher M, Loessner MJ et al. The high-affinity peptidoglycan binding domain of Pseudomonas phage endolysin KZ144. Biochem. Biophys. Res. Commun. 383(2), 187-191 (2009).
33. Loessner MJ, Kramer K, Ebel F, Scherer S. C-terminal domains of Listeria monocytogenes bacteriophage murein hydrolases determine specific recognition and high-affinity binding to bacterial cell wall carbohydrates. Mol. Microbiol. 44(2), 335-349 (2002).
34. Walmagh M, Briers Y, dos Santos SB, Azeredo J, Lavigne R. Characterization of modular bacteriophage endolysins from Myoviridae phages OBP, 201φ2-1 and PVP-SE1. PLoS ONE 7(5), e36991 (2012).
35. Warren RAJ. Engineering β - glycoside hydrolases. In: Protein engineering in industrial biotechnology. Lilia Alberghina (Ed.). Harwood Academic Publishers, London, UK, 162-181 (2005).
36. Vaara M. Agents that increase the permeability of the outer membrane. Microbiol. Rev. 56(3), 395-411 (1992).
37. Nikaido H, Vaara M. Molecular basis of bacterial outer membrane permeability. Microbiol. Rev. 49(1), 1-32 (1985).
38. Morita M, Tanji Y, Mizoguchi K, Soejima A, Orito Y, Unno H. Antibacterial activity of Bacillus amyloliquefaciens phage endolysin without holin conjugation. J Biosci. Bioeng. 91(5), 469-473 (2001).
39. Morita M, Tanji Y, Orito Y, Mizoguchi K, Soejima A, Unno H. Functional analysis of antibacterial activity of Bacillus amyloliquefaciens phage endolysin against Gram-negative bacteria. FEBS Lett. 500(1-2), 56-59 (2001).
40. Orito Y, Morita M, Hori K, Unno H, Tanji Y. Bacillus amyloliquefaciens phage endolysin can enhance permeability of Pseudomonas aeruginosa outer membrane and induce cell lysis. Appl. Microbiol. Biotechnol. 65(1), 105-109 (2004).
41. Lai M-J, Lin N-T, Hu A et al. Antibacterial activity of Acinetobacter baumannii phage AB2 (LysAB2) against both Gram-positive and Gram-negative bacteria. Appl. Microbiol. Biotechnol. 90(2), 529-539 (2011).
42. Lai M-J, Soo P-S, Lin N-T et al. Identification and characterization of the putative phage-related endolysins through full genome sequence analysis is Acinetobacter baumannii ATCC 17978. Int. J. Antimicrob. Agents 42(2), 141-148 (2013).
43. Düring K, Porsch P, Mahn A, Brinkmann O, Gieffers W. The non-enzymatic microbicidal effect of lyzozymes. FEBS Lett. 449(2-3), 93-100 (1999).
44. Düring K, Porsch P, Fladung M, Lörz H. Transgenic potato plants resistant to the phytopathogenic bacterium Erwinia carotovora. Plant J. 3(4), 587-598 (1993).
45. Pellegrini U, Thomas U, Bramaz N, Klauser S, Hunziker P, von Fellenberg R. Identification and isolation of a bactericidal domain in chicken egg white lysozyme. J. Appl. Microbiol. 82(3), 372-378 (1997).
46. Kim JA, Shin H, Heu S, Ryu S. Exogenous lytic activity of SPN9CC endolysin against Gram-negative bacteria. J. Microbiol. Biotechnol. 24(6), 803-811 (2014).
47. Park T, Struck DK, Dankenbring CA, Young R. The pinholin of lambdoid phage 21: control of lysis by membrane depolarization. J. Bacteriol. 189(24), 9135-9139 (2007).
48. Pang T, Park T, Young R. Mutational analysis of the S21 pinholin. Mol. Microbil. 76(1), 68-77 (2010).
49. Koo J, Jahncke ML, Reno PW, Hu X, Mallikarjunan P. Inactivation of Vibrio parahaemolyticus and Vibrio vulnificus in phosphate-buffered saline and in inoculated whole oysters by high-pressure processing. J. Food Prot. 69(3), 596-601 (2006).
50. Masschalck B, Van Houdt R, Michiels CW. High pressure increases bactericidal activity and spectrum of lactoferrin, lactoferricin and nisin. Int. J. Food Microbiol. 64(3), 325-332 (2001).
51. Briers Y, Cornelissen A, Aertsen A et al. Analysis of outer membrane permeability of Pseudomonas aeruginosa and bactericidal activity of endolysins KZ144 and EL188 under high hydrostatic pressure. FEMS Microbiol. Lett. 280(1), 113-119 (2008).
52. Nakimbugwe D, Masschalck B, Atanassova M, Zewdie-Bosüner A, Michiels CW. Comparison of bactericidal activity of six lysozymes at atmospheric pressure and under high hydrostatic pressure. Int. J. Food Microbiol. 108(3), 355-363 (2006).
53. Nakimbugwe D, Masschalck B, Anim G, Michiels CW. Inactivation of gram-negative bacteria in milk and banana juice by hen egg white and lambda lysozyme under high hydrostatic pressure. Int. J. Food Microbiol. 112(1), 19-25 (2006).
54. Briers Y, Walmagh M, Lavigne R. Use of bacteriophage endolysin EL188 and outer membrane permeabilizers against Pseudomonas aeruginosa. J. Appl. Microbiol. 110(3), 778-785 (2011).
55. Ibrahim HR, Higashiguchi S, Juneja LR, Kim M, Yamamoto T. A structural phase of heat-denatured lysozyme with novel antimicrobial action. J. Agric. Food Chem. 44(6), 1416-1423 (1996).
56. Ibrahim HR, Higashiguchi S, Koketsu M et al. Partially unfolded lysozyme at neutral pH agglutinates and kills Gram-negative and Gram-positive bacteria through membrane damage mechanism. J. Agric. Food Chem. 44(12), 3799-3806 (1996).
57. Lukacik P, Barnard T, Keller PW et al. Structural engineering of a phage lysin that targets Gram-negative pathogens. Proc. Natl. Acad. Sci. USA 109(25), 9857-9862 (2012).
58. Lukacik P, Barnard TJ, Buchanan SK. Using a bacteriocin structure to engineer a phage lysin that targets Yersinia pestis. Biochem. Soc. Trans. 40(6), 1503-1506 (2012).
59. Ferber DM, Brubaker RR. Mode of action of pesticin: N-acetylglucosaminidase activity. J. Bacteriol. 139(2), 495-501 (1979).
60. Vollmer W, Pilsl H, Hanthe K, Holtje JV, Braun V. Pesticin displays muramidase activity. J. Bacteriol. 179(5), 1580-1583 (1997).
61. Johnson JR, Stell AL. Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise. J. Infect. Dis. 181(6), 261-272 (2000).
62. Patzer SI, Albrecht R, Braun V, Zeth K. Structural and mechanistic studies of pesticin, a bacterial homolog of phage lysozymes. J. Biol. Chem. 287(28), 23381-23396 (2012).
63. Briers Y, Walmagh M, Van Puyenbroeck V et al. Engineered endolysin-based 'Artilysins' to combat multidrug-resistant Gram-negative pathogens. MBio 5(4), e01379-e01414 (2014).
64. Briers Y, Walmagh M, Grymonprez B et al. Art-175 is a highly efficient antibacterial against multidrug resistant strains and persisters of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 58(7), 3774-3784 (2014).
65. Chan DI, Prenner EJ, Vogel H. Tryptophan-and arginine-rich antimicrobial peptides: structures and mechanisms of action. Biochim. Biophys. Acta 1758(9), 1184-1202 (2006).
66. Lanigan RS, Yamarik TA. Final report on the safety assessment of EDTA, calcium disodium EDTA, diammonium EDTA, dipotassium EDTA, disodium EDTA, TEA-EDTA, tetrasodium EDTA, tripotassium EDTA, trisodium EDTA, HEDTA, and trisodium HEDTA. Int. J. Toxicol. 21(Suppl. 2), 95-142 (2002).
67. Jun SY, Jung GM, Yoon SJ et al. Preclinical safety evaluation of intravenously administered SAL200 containing the recombinant phage endolysin SAL-1 as a pharmaceutical ingredient. Antimicrob. Agents Chemother. 58(4), 2084-2088 (2014).